| |
| |
|
| Insider
Information: |
Thomas Dolca |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Principia Biopharma Inc |
PRNB |
Chief Medical Officer |
2020-09-28 |
0 |
|
0 |
Premium* |
|
|
Chinook Therapeutics Inc |
KDNY |
Director |
2023-08-11 |
0 |
2022-09-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KDNY |
Chinook Therapeutics Inc |
Director |
– • – |
2023-08-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,300) |
0 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Director |
– • – |
2023-05-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,300 |
13,300 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Director |
– • – |
2022-09-02 |
4 |
B |
$21.20 |
$212,194 |
D/D |
10,000 |
10,000 |
2.39 |
% |
|
| PRNB |
Principia Biopharma Inc |
Chief Medical Officer |
• – – |
2020-09-28 |
4 |
D |
$100.00 |
$220,700 |
D/D |
(2,207) |
0 |
0 |
- |
|
| PRNB |
Principia Biopharma Inc |
Chief Medical Officer |
• – – |
2020-08-18 |
4 |
OE |
$23.77 |
$356,550 |
D/D |
15,000 |
16,826 |
0 |
- |
|
| PRNB |
Principia Biopharma Inc |
Chief Medical Officer |
• – – |
2020-08-18 |
4 |
AS |
$100.00 |
$1,500,000 |
D/D |
(15,000) |
1,826 |
0 |
% |
|
| PRNB |
Principia Biopharma Inc |
Chief Medical Officer |
• – – |
2020-07-15 |
4 |
OE |
$23.77 |
$356,550 |
D/D |
15,000 |
16,826 |
0 |
- |
|
| PRNB |
Principia Biopharma Inc |
Chief Medical Officer |
• – – |
2020-07-15 |
4 |
AS |
$80.07 |
$1,201,070 |
D/D |
(15,000) |
1,826 |
0 |
% |
|
| PRNB |
Principia Biopharma Inc |
Chief Medical Officer |
• – – |
2019-12-19 |
4 |
S |
$60.00 |
$29,700 |
D/D |
(495) |
494 |
0 |
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
